CCL2 and pulmonary arterial hypertension: Juglone significantly decreased TNFα-induced expression of MCP-1 at protein level (Fig. 2H) and inhibited the expression levels of MCP-1, RANTES, and TNFα at mRNA level (Fig. 2I) in PAH MVECs.